Medivation To Offer 2.75 Million Common Shares
<p>May 27, 2009 (FinancialWire) — Biopharmaceutical firm Medivation, Inc. (NASDAQ: MDVN) plans to launch an offering of 2.75 million shares of common stock. J.P. Morgan Securities (NYSE: JPM) is acting as sole book-running manager.<span …